Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial.
Authors: Balevic SJ; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina., Benjamin DK Jr; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina., Powderly WG; Division of Infectious Diseases, Department of Medicine, Washington University in St Louis, St Louis, Missouri., Smith PB; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina., Gonzalez D; Duke Clinical Research Institute, Durham, North Carolina., McCarthy MW; Department of Medicine, Weill Cornell Medicine, New York, New York., Shaw LK; Duke Clinical Research Institute, Durham, North Carolina., Lindsell CJ; Duke Clinical Research Institute, Durham, North Carolina., Bozzette S; National Center for Advancing Translational Sciences, Bethesda, Maryland., Williams D; Bristol Myers Squibb, Philadelphia, Pennsylvania., Linas BP; Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts., Blamoun J; Department of Critical Care, MyMichigan Health, Midland., Javeri H; Division of Infectious Diseases, Department of Medicine, University of Texas Health Science Center, San Antonio., Hornik CP; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.
Corporate Authors: ACTIV-1 IM Study Group
Source: JAMA network open [JAMA Netw Open] 2024 Apr 01; Vol. 7 (4), pp. e247615. Date of Electronic Publication: 2024 Apr 01.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38662372
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Balevic+SJ%22">Balevic SJ</searchLink>; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Benjamin+DK+Jr%22">Benjamin DK Jr</searchLink>; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Powderly+WG%22">Powderly WG</searchLink>; Division of Infectious Diseases, Department of Medicine, Washington University in St Louis, St Louis, Missouri.<br /><searchLink fieldCode="AU" term="%22Smith+PB%22">Smith PB</searchLink>; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Gonzalez+D%22">Gonzalez D</searchLink>; Duke Clinical Research Institute, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22McCarthy+MW%22">McCarthy MW</searchLink>; Department of Medicine, Weill Cornell Medicine, New York, New York.<br /><searchLink fieldCode="AU" term="%22Shaw+LK%22">Shaw LK</searchLink>; Duke Clinical Research Institute, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Lindsell+CJ%22">Lindsell CJ</searchLink>; Duke Clinical Research Institute, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Bozzette+S%22">Bozzette S</searchLink>; National Center for Advancing Translational Sciences, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Williams+D%22">Williams D</searchLink>; Bristol Myers Squibb, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Linas+BP%22">Linas BP</searchLink>; Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Blamoun+J%22">Blamoun J</searchLink>; Department of Critical Care, MyMichigan Health, Midland.<br /><searchLink fieldCode="AU" term="%22Javeri+H%22">Javeri H</searchLink>; Division of Infectious Diseases, Department of Medicine, University of Texas Health Science Center, San Antonio.<br /><searchLink fieldCode="AU" term="%22Hornik+CP%22">Hornik CP</searchLink>; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22ACTIV-1+IM+Study+Group%22">ACTIV-1 IM Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101729235%22">JAMA network open</searchLink> [JAMA Netw Open] 2024 Apr 01; Vol. 7 (4), pp. e247615. <i>Date of Electronic Publication: </i>2024 Apr 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101729235 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2574-3805 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225743805%22">25743805 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Netw Open <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38662372
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamanetworkopen.2024.7615
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e247615
    Titles:
      – TitleFull: Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Balevic SJ
      – PersonEntity:
          Name:
            NameFull: Benjamin DK Jr
      – PersonEntity:
          Name:
            NameFull: Powderly WG
      – PersonEntity:
          Name:
            NameFull: Smith PB
      – PersonEntity:
          Name:
            NameFull: Gonzalez D
      – PersonEntity:
          Name:
            NameFull: McCarthy MW
      – PersonEntity:
          Name:
            NameFull: Shaw LK
      – PersonEntity:
          Name:
            NameFull: Lindsell CJ
      – PersonEntity:
          Name:
            NameFull: Bozzette S
      – PersonEntity:
          Name:
            NameFull: Williams D
      – PersonEntity:
          Name:
            NameFull: Linas BP
      – PersonEntity:
          Name:
            NameFull: Blamoun J
      – PersonEntity:
          Name:
            NameFull: Javeri H
      – PersonEntity:
          Name:
            NameFull: Hornik CP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2024 Apr 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2574-3805
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: JAMA network open
              Type: main
ResultId 1